A new oral weight-loss drug from Pfizer could be more effective than the popular Ozempic injection, based on clinical trial results.

Share:
More In Business
The Fed Decides to Hold Rates Steady
Brad Bernstein, managing director at UBS Private Wealth Management breaks down the state of the U.S. economy and what to expect from Fed policy from the rest of the year.
Load More